Skip to main content
Decarbonization project

Shanghai Plant Solar Power System

This project is operational in China.

Status
Operational
Estimated reduction
300 tCO2e a year
Countries
China
Sector
Renewable power
Announced
Not stated
Expected start
2023

About this project

The description is as the source gives it.

Daiichi Sankyo Pharmaceutical (Shanghai) Co., Ltd. installed and began operating a solar power plant in January 2023, following similar installations at other group sites, to expand renewable energy use and reduce CO2 emissions. Evidence: "Daiichi Sankyo Pharmaceutical (Shanghai) Co., Ltd. followed the Onahama Plant and Daiichi Sankyo Europe’s Pfaffenhofen Plant in putting its solar power system into operation... In January 2023, the Daiichi Sankyo Pharmaceutical (Shanghai) Shanghai Plant began using a solar power plant (with annual energy production of approx. ... This is expected to reduce CO2 emissions by 300 tons per year." — https://www.daiichisankyo.com/sustainability/the_environment/climate_strategy/

Statuses, countries and reductions are as the public source states them, and may be out of date.

Project developers can list this project on Carbon3

Project developers can list a project on Carbon3, so that buyers and co-funders can see it. Listing a project costs nothing.

List this project